President Droupadi Murmu To Dedicate CAR-T Cell Therapy To Nation At IIT Bombay

• President Droupadi Murmu will visit Mumbai today, where she will dedicate CAR-T Cell Therapy to the nation at IIT Bombay. The CAR-T Cell Therapy (used to treat cancer patients) has been developed in India by IIT Bombay-incubated Company Immunoadoptive Cell Therapy (ImmunoACT).
• The CAR-T Cell Therapy product has been developed as a collaborative effort between IIT Bombay and Tata Memorial Centre (TMC).
• Designed and developed at IIT Bombay, the therapy has undergone integrative process development and manufacturing at ImmunoACT.
• Clinical investigations and translational studies were conducted by teams at TMH. The CAR-T Cell Therapy product is expected to save many lives at much lower cost compared to the cost of such products available outside India.

Also Read: Science & Technology: Weekly Current Affairs Bitbank (February 19 to 25, 2024): What type of missile is the SAMAR air defence system?

                         >> Download Current Affairs PDFs Here

                              Download Sakshi Education Mobile APP

Published date : 04 Apr 2024 04:21PM